Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 6c, beats revenue
Go back to Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 6c, beats revenue| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 248.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.25 | 52 Week High | $160.00 | |||
| Open | $248.25 | 52 Week Low | $95.80 | |||
| Day High | $248.25 | P/E | 46.14 | |||
| Day Low | $248.25 | EPS | $5.38 | |||
| Volume | 6 | |||||
